Vastarel MR 35 mg contains trimetazidine modified release, a medication used to treat ang
Vastarel MR 35 mg contains trimetazidine modified release, a medication used to treat angina pectoris (chest pain). It works by improving the efficiency of the heart muscle's energy metabolism, thereby increasing its resistance to ischemia (lack of oxygen) and reducing the frequency and severity of angina attacks. Vastarel MR is typically taken once or twice daily, as prescribed by a healthcare professional, and is often used in combination with other medications for angina management.
Related products